Emblation is a medical device company that offers differentiated microwave-based solutions for skin conditions including warts and verrucae. The systems are currently sold in the UK, North America and Australia and have been used in over 130,000 treatments to date.
With its award winning proprietary technology Emblation’s technology delivers superior treatment outcomes. Only a single treatment is needed in most cases with minimum pain and side effects thus being more effective and convenient for patients.
Apposite’s previous investment expertise in this field makes this an extremely attractive opportunity. The company is well positioned for a range of growth opportunities into new markets and indications, and Apposite believes Emblation can emerge as a clear market leader in its field as it already offers competitive advantages against existing standard treatments